Full Text View
Tabular View
No Study Results Posted
Related Studies
Presep and Vascath Interaction Study
This study is currently recruiting participants.
Study NCT00739089   Information provided by Wake Forest University
First Received: August 20, 2008   Last Updated: February 13, 2009   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

August 20, 2008
February 13, 2009
August 2008
change in SvO2 [ Time Frame: before and afer initiation of dialysis via a vascath ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00739089 on ClinicalTrials.gov Archive Site
 
 
 
Presep and Vascath Interaction Study
A Pilot Study to Compare the Interaction Between Central Venous Mixed Venous Oxygen Saturation Catheters and Central Venous Hemodialysis Catheters

This is a prospective, observational study to compare presep(tm) catheter central vein mixed venous oxygen saturation before and after dialysis is initiated via the vascath(tm) central venous dialysis catheter to evaluate device interaction.

The central venous oxygen saturation catheter measurement may be influenced by close approximation to the tip of the central venous hemodialysis catheter when hemodialysis is ongoing.

 
Observational
Case Control, Prospective
  • Hemodynamics
  • Renal Dialysis
  • Sepsis
  • Shock
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
100
 
 

Inclusion Criteria:

  • Admitted to the MICU
  • PreSep venous oxygen saturation central venous catheter already in place
  • VasCath central venous dialysis catheter already in place
  • Planned hemodialysis

Exclusion Criteria:

  • Patient unable to undergo hemodialysis
  • Contraindication for PreSep or VasCath catheters
Both
18 Years and older
No
Contact: Arjun B Chatterjee, MD, MS 336.716.4649 achatter@wfubmc.edu
United States
 
 
NCT00739089
Arjun Chatterjee, Wake Forest University Health Sciences
 
Wake Forest University
 
Principal Investigator: Arjun B Chatterjee, MD, MS Wake Forest University
Wake Forest University
February 2009

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.